Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1962 1
1963 1
1964 5
1965 1
1966 3
1967 2
1968 2
1969 2
1970 3
1971 3
1972 1
1974 9
1975 5
1976 5
1977 3
1978 4
1979 5
1980 5
1981 9
1982 3
1983 7
1984 8
1985 9
1986 12
1987 5
1988 15
1989 14
1990 19
1991 18
1992 14
1993 13
1994 16
1995 20
1996 24
1997 25
1998 24
1999 38
2000 29
2001 41
2002 43
2003 54
2004 50
2005 41
2006 31
2007 28
2008 35
2009 41
2010 38
2011 58
2012 78
2013 67
2014 37
2015 60
2016 46
2017 65
2018 75
2019 110
2020 108
2021 125
2022 44
Text availability
Article attribute
Article type
Publication date

Search Results

1,515 results
Results by year
Filters applied: . Clear all
Page 1
A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T, Uehara H, Akao Y, Ibuki N, Komura K, Takahara K, Takai T, Uchimoto T, Saito K, Tanda N, Yoshikawa Y, Minami K, Hirano H, Nomi H, Kato R, Hayashi T, Azuma H. Inamoto T, et al. Among authors: yoshikawa y. Dis Markers. 2018 Jun 20;2018:5468672. doi: 10.1155/2018/5468672. eCollection 2018. Dis Markers. 2018. PMID: 30026881 Free PMC article.
Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury.
Redd MA, Scheuer SE, Saez NJ, Yoshikawa Y, Chiu HS, Gao L, Hicks M, Villanueva JE, Joshi Y, Chow CY, Cuellar-Partida G, Peart JN, See Hoe LE, Chen X, Sun Y, Suen JY, Hatch RJ, Rollo B, Xia D, Alzubaidi MAH, Maljevic S, Quaife-Ryan GA, Hudson JE, Porrello ER, White MY, Cordwell SJ, Fraser JF, Petrou S, Reichelt ME, Thomas WG, King GF, Macdonald PS, Palpant NJ. Redd MA, et al. Among authors: yoshikawa y. Circulation. 2021 Sep 21;144(12):947-960. doi: 10.1161/CIRCULATIONAHA.121.054360. Epub 2021 Jul 15. Circulation. 2021. PMID: 34264749 Free article.
Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression.
Chakraborty G, Armenia J, Mazzu YZ, Nandakumar S, Stopsack KH, Atiq MO, Komura K, Jehane L, Hirani R, Chadalavada K, Yoshikawa Y, Khan NA, Chen Y, Abida W, Mucci LA, Lee GM, Nanjangud GJ, Kantoff PW. Chakraborty G, et al. Among authors: yoshikawa y. Clin Cancer Res. 2020 Apr 15;26(8):2047-2064. doi: 10.1158/1078-0432.CCR-19-1570. Epub 2019 Dec 3. Clin Cancer Res. 2020. PMID: 31796516 Free PMC article.
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
Ando Y, Kawaoka T, Amioka K, Naruto K, Ogawa Y, Yoshikawa Y, Kikukawa C, Kosaka Y, Uchikawa S, Morio K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Tsuge M, Hiramatsu A, Fukuhara T, Mori N, Takaki S, Tsuji K, Nonaka M, Hyogo H, Aisaka Y, Masaki K, Honda Y, Moriya T, Naeshiro N, Takahashi S, Imamura M, Chayama K, Aikata H. Ando Y, et al. Among authors: yoshikawa y. Oncology. 2021;99(8):507-517. doi: 10.1159/000515865. Epub 2021 May 4. Oncology. 2021. PMID: 33946070
Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO-Kyoto Thrombotic and Bleeding Risk Scores.
Natsuaki M, Morimoto T, Yamaji K, Watanabe H, Yoshikawa Y, Shiomi H, Nakagawa Y, Furukawa Y, Kadota K, Ando K, Akasaka T, Hanaoka KI, Kozuma K, Tanabe K, Morino Y, Muramatsu T, Kimura T; CREDO‐Kyoto PCI/CABG Registry Cohort 2, RESET, and NEXT trial investigators. Natsuaki M, et al. Among authors: yoshikawa y. J Am Heart Assoc. 2018 May 22;7(11):e008708. doi: 10.1161/JAHA.118.008708. J Am Heart Assoc. 2018. PMID: 29789335 Free PMC article.
Demographics, Management, and In-Hospital Outcome of Hospitalized Acute Heart Failure Syndrome Patients in Contemporary Real Clinical Practice in Japan - Observations From the Prospective, Multicenter Kyoto Congestive Heart Failure (KCHF) Registry.
Yaku H, Ozasa N, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Sasaki K, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kato T, Kimura T; KCHF Study Investigators. Yaku H, et al. Among authors: yoshikawa y. Circ J. 2018 Oct 25;82(11):2811-2819. doi: 10.1253/circj.CJ-17-1386. Epub 2018 Sep 26. Circ J. 2018. PMID: 30259898 Free article. Clinical Trial.
Temperature Dependence of Polymer Network Diffusion.
Fujiyabu T, Sakai T, Kudo R, Yoshikawa Y, Katashima T, Chung UI, Sakumichi N. Fujiyabu T, et al. Among authors: yoshikawa y. Phys Rev Lett. 2021 Dec 3;127(23):237801. doi: 10.1103/PhysRevLett.127.237801. Phys Rev Lett. 2021. PMID: 34936791
In reply: Why remifentanil?
Sakai W, Yoshikawa Y, Yamakage M. Sakai W, et al. Among authors: yoshikawa y. J Anesth. 2018 Jun;32(3):459. doi: 10.1007/s00540-018-2487-7. Epub 2018 Apr 3. J Anesth. 2018. PMID: 29616346 No abstract available.
Evaluation of Eye-Pain Severity between Dry-Eye Subtypes.
Yoshikawa Y, Yokoi N, Kato H, Sakai R, Komuro A, Sonomura Y, Ikeda T, Sotozono C. Yoshikawa Y, et al. Diagnostics (Basel). 2021 Jan 25;11(2):166. doi: 10.3390/diagnostics11020166. Diagnostics (Basel). 2021. PMID: 33503963 Free PMC article.
1,515 results